Skip to content
Disclosery

REGENERON PHARMACEUTICALS, INC.: ACET position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of REGENERON PHARMACEUTICALS, INC. on ACET, newest first. How the timeline and the estimate are built.

REGENERON PHARMACEUTICALS, INC. held 60,511 ACET shares at 2026-06-30 per its 13F-HR filed 2026-08-07.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 60,511 shares
    Change vs previous 13F not available

    0.3% of the 13F portfolio, value $522,819.

    13F-HR 0001104659-26-092709 filed by REGENERON PHARMACEUTICALS, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec ยง4.2).